Harrow, Inc. HROW
NASDAQ · United States · Health Technology
$30.59-0.21 (-0.68%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-10 | -0.46 | -0.18 | -157.3% | $70.66M | +0.4% | -2.5%$40.44→$39.42 |
| Q1 2026 | 2026-05-11 | -0.74 | -0.33 | -124.2% | — | — | -24.1%$38.23→$29.03 |
| Q4 2025 | 2026-03-02 | 0.17 | 0.37 | -54.1% | — | — | -28.7%$54.18→$38.61 |
| Q3 2025 | 2025-11-10 | 0.33 | 0.29 | +13.8% | — | — | +14.2%$33.93→$38.74 |
| Q2 2025 | 2025-08-11 | 0.24 | 0.04 | +500.0% | — | — | — |
| Q4 2024 | 2025-03-27 | 0.40 | 0.13 | +207.7% | — | — | — |
| Q3 2024 | 2024-11-13 | -0.05 | 0.07 | -171.4% | — | — | — |
| Q1 2024 | 2024-05-13 | -0.28 | -0.25 | -12.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.